Anti-ENA antibodies were also seen significantly more often in the SRP group compared to the PRP group: 50.0% of the SRP patients and 4.8% of the PRP patients showed anti-ENA antibodies (p = 0.001) (Table 1). This evidence concerns the gene ENAH and short rib dysplasia.